Clinical Trial Update: Low Dose Intravenous (IV) Infusion of BNP in the Presence and Absence of Acute Type V Phosphodiesterase (PDE V) in Improving Renal Function in Hospitalized Chronic Heart Failure (CHF) Patients With Renal Dysfunction [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating low-dose intravenous BNP infusion for improving renal function in hospitalized heart failure patients with renal dysfunction, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Renal Dysfunction

Drugs mentioned

• BNP (b-type natriuretic peptide)

Snippet

Sponsor: Mayo Clinic | Conditions: Heart Failure, Renal Dysfunction | Phase 1, Phase 2 | Status: COMPLETED